cGAS–STING 信号通路相关靶向药物研究进展
摘要
作用同时该通路的异常会导致各种免疫疾病的发生因而开发针对该信号通路的靶向性药物至关重要本文就 cGASSTING 信号通路中最关键的两个蛋白 cGAS 以及 STING 的靶向性药物的研究进展进行讨论以期为临床药物的进一步研
发提供参考和思路。
关键词
全文:
PDF参考
[1] 唐庭轩 , 郭凯文 .SARS-CoV-2 病毒逃避固有免疫
应答的机制研究进展 [J]. 生命的化学 ,2022,42(02):338-342.
[2] Motwani M, Pesiridis S, Fitzgerald K A. DNA sensing
by the cGAS-STING pathway in health and disease[J]. Nat Rev
Genet, 2019, 20(11): 657-674.
[3] Yu L, Liu P. Cytosolic DNA sensing by cGAS:
regulation, function, and human diseases[J]. Signal Transduct
Target Ther, 2021, 6(1) [2021-08-30].
[4] Cheng Z, Dai T, He X, et al. The interactions between
cGAS-STING pathway and pathogens[J]. Signal Transduct Target
Ther, 2020, 5(1) [2021-08-30].
[5] Chen Q, Sun L, Chen Z J. Regulation and function of the
cGAS-STING pathway of cytosolic DNA sensing[J]. Nat Immunol,
2016, 17(10): 1142-1149.
[6] Wan D, Jiang W, Hao J. Research advances in how
the cGAS-STING pathway controls the cellular inflammatory
response[J]. Front Immunol, 2020, 11 [2021-08-30].
[7] An J, Minie M, Sasaki T, et al. Antimalarial Drugs as
Immune Modulators: New Mechanisms for Old Drugs[J]. Annu Rev
Med, 2017, 68: 317-330.
[8] Vincent J, Adura C, Gao P, et al. Small molecule
inhibition of cGAS reduces interferon expression in primary
macrophages from autoimmune mice[J]. Nat Commun, 2017, 8(1):
1-13.
[9] Hall J, Brault A, Vincent F, et al. Discovery of PF-
06928215 as a high affinity inhibitor of cGAS enabled by a
novel fluorescence polarization assay[J]. PLoS One, 2017, 12(9):
e0184843.
[10] Chu L, Li C, Li Y, et al. Perillaldehyde inhibition of
cGAS reduces dsDNA-induced interferon response[J]. Front
Immunol, 2021, 12: 1201.
[11] Haipeng Liu, Hang Su, Fei Wang, et al. Pharmacological
boosting of cGAS activation sensitizes chemotherapy by enhancing
antitumor immunity[J]. Cell Reports, 2023, 42(3): 112275.
[12] Shang G, Zhang C, Chen Z J, et al. Cryo-EM structures
of STING reveal its mechanism of activation by cyclic GMP
AMP[J]. Nature, 2019, 567(7748) 389-393.
[13] Kato K, Omura H, Ishitani R, et al. Cyclic GMP-AMP
as an endogenous second messenger in innate immune signaling
by cytosolic DNA[J]. Annu Rev Biochem, 2017, 86: 541-566.
[14] Mukai K, Konno H, Akiba T, et al. Activation of STING
requires palmitoylation at the Golgi[J]. Nat Commun, 2016,
7:11932.
[15] Haag SM, Gulen MF, Reymond L, et al. Targeting
STING with covalent small-molecule inhibitors[J]. Nature, 2018,
559(7713): 269-273.
[16] Hansen AL, Buchan GJ, Ruhl M, et al. Nitro-fatty acids
are formed in response to virus infection and are potent inhibitors
of STING palmitoylation and signaling[J]. Proc Natl Acad Sci USA,
2018, 115(33): E7768-E7775.
[17] Siu T, Altman M D, Baltus G A, et al. Discovery of a
novel cGAMP competitive ligand of the inactive form of STING[J].
ACS Med Chem Lett, 2018, 10(1): 92-97.
[18] Hong Z, Mei J, Li C, et al. STING inhibitors target the
cyclic dinucleotide binding pocket[J]. PNAS, 2021, 118(24):
e2105465118.
[19] Li S, Hong Z, Wang Z, et al. The cyclopeptide astin C
specifically inhibits the innate immune CDN sensor STING[J].
Cell reports, 2018, 25(12): 3405-3421.
[20] Liu H, Moura-Alves P, Pei G, et al. cGAS facilitates
sensing of extracellular cyclic dinucleotides to activate innate
immunity[J]. EMBO Rep, 2019, 20(4): e46293.
[21] Amouzegar A, Chelvanambi M, Filderman J N, et al.
STING agonists as cancer therapeutics[J]. Cancers, 2021, 13(11):
2695.
[22] Berger G, Lawler S E. Novel non-nucleotidic STING
agonists for cancer immunotherapy[J]. Future Med Chem, 2018,
10(24): 2767-2769.
[23] Wang C, Sinn M, Stifel J, et al. Synthesis of All Possible
Canonical (3’-5’-Linked) Cyclic Dinucleotides and Evaluation
of Riboswitch Interactions and Immune-Stimulatory Effects[J]. J
Am Chem Soc, 2017, 139(45): 16154-16160.
[24] Ramanjulu J M, Pesiridis G S, Yang J, et al. Design
of amidobenzimidazole STING receptor agonists with systemic
activity[J]. Nature, 2018, 564(7736): 439-443.
[25] Gao P, Zillinger T, Wang W, et al. Binding-pocket and
lid-region substitutions render human STING sensitive to the
species-specific drug DMXAA[J]. Cell Rep, 2014, 8(6): 1668-
1676.
(7 摘要 Views, 36 PDF Downloads)
Refbacks
- 当前没有refback。